Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).

Sherry ShenJoseph M UngerKatherine D CrewCathee TillHeather GreenleeJulie GralowShaker R DakhilLori M MinasianJames L WadeMichael J FischN Lynn HenryDawn L Hershman

Published in: Breast cancer research and treatment (2018)

In obese BC patients, O3-FA use was associated with significantly reduced AI arthralgia compared to placebo.

Keyphrases

end stage renal disease
adipose tissue
fatty acid
metabolic syndrome
weight loss
ejection fraction
newly diagnosed
chronic kidney disease
type diabetes
prognostic factors
artificial intelligence
randomized controlled trial
obese patients
clinical trial
machine learning
deep learning
study protocol